Cambridge, United Kingdom · Founded 2017 · Privately Held (backing)
Developer of a non-invasive diagnostic platform designed for the early detection of cancer. Mursla Bio is based in Cambridge, United Kingdom and was founded in 2017. Its last reported valuation was $53.2 million in Apr 2025. It has raised $10.2 million.
Last reported valuation
$53.2M
Oct 2026
Priced at
—
Total raised
$10.2M
Last round
—
Team — not yet on record
No current team members for Mursla Bio are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Private Market View
More of Mursla Bio with a free Private Market View account
·Watch Mursla Bio: the Monday email on marks, rounds and moves
